SubjectWell Introduces OneView Portal to Revolutionize Patient Recruitment and Clinical Trials
In the constantly evolving field of clinical development, clinical trial participation often faces significant hurdles, with as many as 80% of trials failing to meet their enrollment timelines. This situation has prompted immune system weakening with losses tallying up to a staggering $40 billion annually. But one company is stepping up to change this narrative: SubjectWell.
On February 3, 2025, SubjectWell unveiled its groundbreaking OneView patient recruitment portal, alongside an impactful rebranding initiative. Led by CEO Fred Martin, SubjectWell aims to tackle the core challenges impacting patient recruitment by integrating a comprehensive and user-friendly platform that enhances efficiency for both clinical trial sponsors and participating sites.
"The market demands disruptive solutions, and OneView provides just that," Martin stated at the launch event. The portal serves a dual purpose: it simplifies the recruitment ecosystem for sponsors and clinical research organizations (CROs) while offering clinical sites a streamlined method for managing patient data and recruitment metrics.
OneView is designed to improve interoperability, allowing users to view and manage multiple recruitment programs through a single system. This real-time access empowers sponsors and CROs to swiftly assess their recruitment efforts and make informed, critical decisions. For clinical sites, the portal ensures quick access to performance indicators, helping to minimize technological burdens and allowing a stronger focus on patient care.
The rebranding to SubjectWell 2.0 is also noteworthy; it reflects a commitment to innovation and a modernized approach in the patient recruitment sphere. "Our revitalized brand not only aims to humanize our presence in the market but also serves as a call to embrace sophisticated technology, global outreach, and enhanced services that have the potential to upend traditional practices in patient recruitment," noted Martin.
As part of the rollout, SubjectWell will participate in the upcoming 16th Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida, from February 3-6, where they will showcase OneView and their rebranding initiative.
SubjectWell has already established a global footprint with a patient-centric technology platform that connects over 13 million patients, offering diverse recruiting capabilities across 102 countries. Their services, which are designed to alleviate the burdens placed on research sites, are supported by a robust digital media network.
By addressing the pressing challenges within patient recruitment and transforming the dynamics of clinical trials, SubjectWell is not just aiming for efficiency; they're positioning themselves as a driver of innovation in healthcare. For more details, interested parties are encouraged to visit www.subjectwell.com.
With advancements like OneView, SubjectWell exemplifies the forward-thinking solutions the clinical development industry requires to succeed in a landscape where patient enrollment is paramount for trial success.
Overall, the introduction of the OneView portal marks a significant stride forward for SubjectWell, promising to enhance the entire process of patient recruitment while keeping the focus firmly on patient-centric outcomes. This kind of disruption could very well reshape the future of clinical trials as we know them.
On February 3, 2025, SubjectWell unveiled its groundbreaking OneView patient recruitment portal, alongside an impactful rebranding initiative. Led by CEO Fred Martin, SubjectWell aims to tackle the core challenges impacting patient recruitment by integrating a comprehensive and user-friendly platform that enhances efficiency for both clinical trial sponsors and participating sites.
"The market demands disruptive solutions, and OneView provides just that," Martin stated at the launch event. The portal serves a dual purpose: it simplifies the recruitment ecosystem for sponsors and clinical research organizations (CROs) while offering clinical sites a streamlined method for managing patient data and recruitment metrics.
OneView is designed to improve interoperability, allowing users to view and manage multiple recruitment programs through a single system. This real-time access empowers sponsors and CROs to swiftly assess their recruitment efforts and make informed, critical decisions. For clinical sites, the portal ensures quick access to performance indicators, helping to minimize technological burdens and allowing a stronger focus on patient care.
The rebranding to SubjectWell 2.0 is also noteworthy; it reflects a commitment to innovation and a modernized approach in the patient recruitment sphere. "Our revitalized brand not only aims to humanize our presence in the market but also serves as a call to embrace sophisticated technology, global outreach, and enhanced services that have the potential to upend traditional practices in patient recruitment," noted Martin.
As part of the rollout, SubjectWell will participate in the upcoming 16th Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida, from February 3-6, where they will showcase OneView and their rebranding initiative.
SubjectWell has already established a global footprint with a patient-centric technology platform that connects over 13 million patients, offering diverse recruiting capabilities across 102 countries. Their services, which are designed to alleviate the burdens placed on research sites, are supported by a robust digital media network.
By addressing the pressing challenges within patient recruitment and transforming the dynamics of clinical trials, SubjectWell is not just aiming for efficiency; they're positioning themselves as a driver of innovation in healthcare. For more details, interested parties are encouraged to visit www.subjectwell.com.
With advancements like OneView, SubjectWell exemplifies the forward-thinking solutions the clinical development industry requires to succeed in a landscape where patient enrollment is paramount for trial success.
Overall, the introduction of the OneView portal marks a significant stride forward for SubjectWell, promising to enhance the entire process of patient recruitment while keeping the focus firmly on patient-centric outcomes. This kind of disruption could very well reshape the future of clinical trials as we know them.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.